CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A...e.u. Development and License Agreement • May 9th, 2019 • Pfenex Inc. • Pharmaceutical preparations • New York
This E.U. Development and License Agreement (this “Agreement”) is entered into as of February 25, 2019 (the “Effective Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex” or a “Party”), and Alvogen Malta (Out-licensing) Ltd., a Maltese corporation (“Alvogen” or a “Party”, and together with Pfenex, the “Parties”).
